CMS Pub. 100-04, ch. 18, § 10.2.1

Vaccines and their administration are reported using separate codes. The following codes are for reporting the

vaccines only.

HCPC Definition

90630 Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative

free, for intradermal use

90653 Influenza virus vaccine, inactivated, subunit, adjuvanted, for

intramuscular use

90654 Influenza virus vaccine, split virus, preservative-free, for intradermal

use, for adults ages 18 – 64;

90655 Influenza virus vaccine, split virus, preservative free, for children 6-

35 months of age, for intramuscular use;

90656 Influenza virus vaccine, split virus, preservative free, for use in

individuals 3 years and above, for intramuscular use;

90657 Influenza virus vaccine, split virus, for children 6-35 months of age,

for intramuscular use;

90658 Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage,

for intramuscular use

90660 Influenza virus vaccine, live, for intranasal use;

90661 Influenza virus vaccine, derived from cell cultures, subunit,

preservative and antibiotic free, for intramuscular use

90662 Influenza virus vaccine, split virus, preservative free, enhanced

immunogenicity via increased antigen content, for intramuscular use

90670 Pneumococcal conjugate vaccine, 13 valent, for intramuscular use

90671 Pneumococcal conjugate vaccine, 15 valent (PCV15), for

intramuscular use

90672 Influenza virus vaccine, live, quadrivalent, for intranasal use

90673 Influenza virus vaccine, trivalent, derived from recombinant DNA

(RIV3), hemagglutinin (HA) protein only, preservative and antibiotic

free, for intramuscular use

90674 Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell

cultures, subunit, preservative and antibiotic free, 0.5 mL dosage,

for intramuscular use

90677 Pneumococcal conjugate vaccine, 20 valent (PCV20), for

intramuscular use

90682 Influenza virus vaccine, quadrivalent (RIV4), derived from

recombinant DNA, hemagglutinin (HA) protein only, preservative

and antibiotic free, for intramuscular use

90685 Influenza virus vaccine, quadrivalent, split virus, preservative free,

when administered to children 6-35 months of age, for intramuscular

use

90686 Influenza virus vaccine, quadrivalent, split virus, preservative free,

when administered to individuals 3 years of age and older, for

intramuscular use

90687 Influenza virus vaccine, quadrivalent, split virus, when

administered to children 6-35 months of age, for intramuscular use

90688 Influenza virus vaccine, quadrivalent, split virus, when

90694

administered to individuals 3 years of age and older, for

intramuscular use

Influenza virus vaccine, quadrivalent (aIIV4), inactivated,

90732 Pneumococcal polysaccharide vaccine, 23-valent, adult or

immunosuppressed patient dosage, for us in individuals 2 years

or older, for subcutaneous or intramuscular use;

90739 Hepatitis B vaccine, adult dosage (2 dose schedule), for

intramuscular use

90740 Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (3

dose schedule), for intramuscular use;

90743 Hepatitis B vaccine, adolescent (2 dose schedule), for intramuscular

use;

90744 Hepatitis B vaccine, pediatric/adolescent dosage (3 dose schedule),

for intramuscular use;

90746 Hepatitis B vaccine, adult dosage, for intramuscular use; and

90747 Hepatitis B vaccine, dialysis or immunosuppressed patient dosage (4

dose schedule), for intramuscular use.

90756 Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell

cultures, subunit, antibiotic free, 0.5mL dosage, for intramuscular use

90759 Hepatitis B vaccine (HepB), 3-antigen (S, Pre-S1, Pre-S2), 10 mcg

Note: COVID-19 vaccine and administration HCPCS are temporarily posted at:

https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/covid-19-vaccines-and-

monoclonal-antibodies.

Note: For the Medicare-covered codes for the influenza vaccines approved by the Food and Drug

Administration (FDA) for the current influenza vaccine season, please go

to: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Part-B-

Drugs/McrPartBDrugAvgSalesPrice/VaccinesPricing.html

The following codes are for reporting administration of the vaccines only. The administration of the vaccines is

billed using:

* NOTE: Beginning January 1, 2011, providers should report G0010 for billing under the OPPS rather than

90471 or 90472 to ensure correct waiver of coinsurance and deductible for the administration of hepatitis B

vaccine.

NOTE: COVID-19 vaccine and administration HCPCS are temporarily posted at:

https://www.cms.gov/medicare/medicare-part-b-drug-average-sales-price/COVID-19-vaccines-and-

monoclonal-antibodies.

The following diagnosis code must be reported. If the sole purpose for the visit is to receive a vaccine or if a

vaccine is the only service billed on a claim, the applicable following diagnosis code may be used.

ICD-10-CM

Diagnosis Code

Description

Z23 Encounter for Immunization

NOTE: ICD-10-CM diagnosis code Z23 is to be used for all encounters for preventive vaccine immunizations,

including COVID-19 immunizations.

The following condition code must be reported on institutional claims when diagnosis code Z23 is required for a

vaccination.

Condition Code Description

A6 Vaccine / Medicare 100% Payment

All claims must have the appropriate diagnosis code, procedure, and admin code to process correctly.